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MinireviewWagging the Dogma: Tissue-
Specific Cell Cycle Control
in the Mouse Embryo
Many E2F targets (including cyclin A, cyclin E, and vari-
ous replication factors) are important for the G1/S transi-
tion and DNA replication. Cyclin D-Cdk4/6 complexes
have also been suggested to drive cell cycle progression
by sequestering the CKIs p21 and p27, two potent inhibi-
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& Immunology tors of cyclin E-Cdk2 and cyclin A-Cdk2 as well as cyclin
A-Cdk1 and cyclin B-Cdk1. Released from the inhibitoryStanford University School of Medicine
300 Pasteur Drive effect of p21 and p27, activated Cdk2/1 complexes have
been suggested to further phosphorylate Rb and otherPalo Alto, California 94305
downstream substrates and thereby drive progression
toward mitosis. Cyclin D may have other roles either
requiring or independent of Cdk4, Cdk6, or Rb (see,
for example, cyclin D-Cdk4 phosphorylation of Smad3The family of cyclin-dependent kinases (Cdks) lies at
[Matsuura et al., 2004]). Even the regulation of Rb bythe core of the machinery that drives the cell division
cyclin D-Cdk complexes may activate not only transcrip-cycle. Studies in cultured mammalian cells have pro-
tion, but also other programs including chromatin re-vided insight into the cellular functions of many Cdks.
modeling and the initiation of DNA replication by directlyRecent Cdk and cyclin knockouts in the mouse show
regulating origin firing.that the functions of G1 cell cycle regulatory genes
Cell Cycle Control by D-Type Cyclinsare often essential only in specific cell types, pointing
in the Developing Embryoto our limited understanding of tissue-specific expres-
Recent studies from the Barbacid and Sicinski groupssion, redundancy, and compensating mechanisms in
report the effect of deleting both Cdk4 and Cdk6 genesthe Cdk network.
(Malumbres et al., 2004) or all three D type cyclins (Kozar
et al., 2004) in the mouse. In both cases, lethality isEukaryotic cells rely on the presence of cyclin-depen-
observed at around embryonic day 16, accompanied bydent kinases (Cdks) for their division. In addition to the
a major failure in hematopoesis including erythropoesis,catalytic subunit (the Cdk itself), each Cdk complex con-
which is the likely cause of death (Table 1). In contrast,tains one of many activating subunits called cyclins be-
most organogenesis and tissue development appearscause their levels fluctuate periodically throughout the
unaffected. Thus, it seems that the majority of embryoniccell cycle. Distinct cyclin-Cdk complexes power the cell
tissues are “cyclin D independent,” whereas hema-through different phases of the cell cycle. In mammals,
topoesis is “cyclin D dependent.” Nonetheless, thethese complexes include the D-type cyclins (cyclins D1,
embryos show reduced body size, underscoring the im-D2, and D3), which activate Cdk4 and Cdk6 to execute
portance of these Cdks in controlling overall cell pro-critical regulatory events in G1; the E-type and A-type
liferation or tissue growth. The decrease in proliferativecyclins, which activate Cdk2 to effect events in S phase
potential is particularly visible in vitro, where both T cellsincluding DNA replication and centrosome duplication;
and mouse embryonic fibroblasts (MEFs) are reducedand the A-type cyclins (in a second role) and B-type
in their ability to proliferate in response to mitogens.cyclins, which activate Cdk1 to direct structural and
In addition, in MEFs from the cyclin D1/D2/D3/regulatory events in mitosis. Inactivation of Cdk1 in late
mouse, a higher dependency on serum is observed andmitosis contributes to reset the cell in G1. In addition
these cells are less susceptible to oncogenic transfor-to positive regulation by cyclins, Cdks are regulated by
mation, supporting the overwhelming literature thatmultiple phosphorylation and dephosphorylation events
shows a role for G1 Cdks in serum responses and cellu-and by several subunits named CKIs (for Cdk inhibitors)
lar transformation. These serum response and transfor-that physically associate with cyclin-Cdk complexes to
mation pathways therefore appear to be different thaninhibit their activities and promote cell cycle arrest or
the embryonic pathways important for organogenesisdelay.
in many tissues.Among the cyclins, the seminal observation that dif-
The embryonic deficiency in hematopoesis clearlyferent cyclin D family members are transcriptionally in-
demonstrates the importance of D-type cyclins or theirduced in response to extracellular signals, including
associated Cdks in specific tissues. Analysis of adultgrowth factors (Matsushime et al., 1991), led to the hy-
mutant mice lacking a single D cyclin, Cdk4 or Cdk6,pothesis that D-type cyclins represent crucial intermedi-
has demonstrated that most of these proteins supportaries for transmitting signals from the extracellular envi-
tissue-specific functions (Table 1), although not causingronment, through cell signaling pathways, to activate
strict lethality. Indeed, some phenotypes observed inthe cell cycle machinery. Cdk4 and Cdk6 catalyze the
the single knockouts are probably masked in the triplephosphorylation of the retinoblastoma (Rb) tumor sup-
knockout because of its earlier lethality. A similar con-pressor gene product to disrupt its association with
clusion for tissue-specific functions can be drawn bymembers of the E2F family of transcription factors,
examining the phenotypes of mice lacking genes encodingthereby promoting transcription of E2F target genes.
other cyclins and Cdks (see comprehensive list in Sup-
plemental Table S1 at http://www.cell.com/cgi/content/*Correspondence: michele.pagano@med.nyu.edu (M.P.), pjackson@
stanford.edu (P.K.J.) full/118/5/535/DC1) as well as Cdk regulators, such as
Cell
536
Table 1. Phenotypes Associated with Homozygous Loss of D Type Cyclins or Associated Cdks
Genotypea Major In Vivo Phenotype/s Phenotype Observed in Tissue Culture
D1/ Postnatal lethality; Reduced body size; Small cerebellum; behavior/neurological MEFs showed slightly reduced growth
abnormalities; Hypoplastic retina; Defects in lactation due to lack of but normal proliferation
proliferation of the mammary epithelium Reduced susceptibility to
breast cancer
D2/ Female infertility (inability of granulosa cells to proliferate, but normal oocytes); Prolonged G1 in B lymphocytes
Males were fertile but displayed small testes and decreased sperm count;
Small cerebellum; Pancreatic beta cell hypoplasia
D3/ Decreased expansion of immature T lymphocytes; Reduced susceptibility Decreased T cell proliferation
to certain T cell malignancies
D1/D2/ Reduced body size; Undeveloped cerebellum Not tested
D1/D3/ Neonatal lethality (likely due to neurological defects); Reduced body size; Not tested
Hypoplastic retina
D2/D3/ Embryonic lethality (E18.5); Severe megaloblastic anemia; Not tested
Reduced body size
D1/D2/D3/ Embryonic lethality (E16) Reduced proliferation in hematopoietic
Multi-lineage hematopoietic failure; Reduced body size; Cardiac abnormality cells and MEFs
Cdk2 silencing reduced dramatically
proliferation in MEFs
Reduced susceptibility to oncogenic
transformation
Cdk4/ Viable but slightly lower ratio of homozygotes (19.6%); Reduced body size MEFs showed reduced proliferation
Behavior/neurological abnormalities; Pancreatic beta cell hypoplasia 80%
males were sterile with small testes and reduced numbers of sperm cells
Females were infertile (small ovaries, defect in corpus luteum formation)
Cdk6/ Decreased expansion of immature T lymphocytes Decreased T cell proliferation
Cdk4/Cdk6/ Embryonic lethality (between E 14.5 and E18.5); Multilineage hematopoietic failure; Reduced proliferation in T cells and
Reduced body size MEFs; Cdk2 silencing reduced
dramatically proliferation in MEFs
a A more comprehensive list of phenotypes associated with homozygous loss of cyclins or Cdks is presented in the Supplemental Data at
http://www.cell.com/cgi/content/full/118/5/535/DC1.
CKI family members (reviewed by Ortega et al. [2002]), Another notion challenged by these two studies is
the above-mentioned sequestration model. One wouldCdc25b (Lincoln et al., 2002), Cdc25c (Chen et al., 2001),
Skp2 (Nakayama et al., 2000), Trcp1 (Guardavaccaro naively expect that in the absence of D cyclin com-
plexes, more p21 and p27 would bind to Cdk2, but thiset al., 2003), Dp1 (Kohn et al., 2004), and E2F and Rb
family members (reviewed by Yamasaki [2003]). In fact, was not observed. However, less p21 and p27 were
present in the cyclin D- and Cdk4/6-deficient cells, par-so far, only cyclin A2, cyclin B1 (see Supplemental Table
S1), and Apc2 (Wirth et al., 2004) are essential in early ticularly during G1. Functionally, by having lower levels
of Cdk inhibitors, there would also be a reduced require-embryogenesis, supporting the fundamental impor-
tance of regulation by mitotic cyclins. Differential ex- ment for cyclin D-dependent sequestration of CKIs. The
reduction in p21 and p27 may reflect a failure to seques-pression of D cyclins and their inhibitors (the four mem-
bers of the INK family of CKIs) in human tissues is also ter and thus accumulate these regulators in complex
with cyclin D-Cdk. So, both the sequestration modelconsistent with cell type-specific roles.
At a molecular level, the proliferation defects in the and the mechanism by which the embryo compensates
to reduce p21 and p27 levels will require further testing.cyclin D triple knockout MEFs correspond to a delay in
the induction of E2F target genes and a decrease, but Reordering Models and Expectations?
Despite earlier evidence for cell type-specific expres-not elimination, of Rb phosphorylation on previously
described cyclin D-dependent sites (Ser248, Thr252, sions and functions, because of their roles in coupling
growth factor signaling to cell cycle, loss of D-typeThr826, Ser807, and Ser811). The existing model held
that these sites would prime phosphorylation by cyclin cyclins might have been expected to show dramatic
proliferation defects in the mouse embryo, similar toE- or cyclin A-Cdk2 complexes. However, the levels
of phosphorylation on the cyclin E-, cyclin A-specific those seen in cyclin A2 or cyclin B1 knockouts. There
were even higher expectations for E cyclins and Cdk2,residue Thr821 were almost identical to wild-type MEFs,
arguing against the notion that the phosphorylation on which are thought to be expressed in most if not all
cells. Nonetheless, mouse knockouts for either cyclinthese sites is strictly dependent on cyclin D-Cdk com-
plexes. Indeed, in the cyclin D1/D2/D3/ MEFs, the E1 or E2 (see Supplemental Table S1) were also viable.
Thus, following the history of the logic, when it becamekinetics of timing and rapid activation of cyclin E- and
cyclin A-associated kinases was not strongly affected, evident that embryos can develop normally and adult
mice exist without one, and in some cases two, of thefurther suggesting that D-type cyclins are not a neces-
sary prerequisite for activation of the other G1 and S cyclin D or cyclin E genes, it was postulated that loss
of all three D-type cyclins (or lacking Cdk4 and Cdk6)phase cyclins. There was also a reduction in the levels
of phosphorylation of the Rb-related p107. The other or the two E-type cyclins (or lacking Cdk2) would do
the trick. Having now found that cyclin E-Cdk2 com-family member, p130, thought to be important for G1/S
control, has not yet been tested. plexes are not required for viability and that cyclin
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D-Cdk4/6 complexes are not required for most tissues function to maintain cell proliferation in the presence of
high glucose (Lorenz et al., 2003).to develop, we may need to reexamine the model for how
One synthesis of these findings is that cyclin D-Cdkthese cyclins contribute to mammalian cell proliferation
complexes may couple various kinds of time-varying,during development and thereafter.
homeostatic (turbo-charged) signals (growth factors,On the surface, these genetic observations in the
nutrients, oxygen, etc.) to cell cycle division. This signal-mouse seem to require a radical reorientation of current
ing-linked proliferation may be most important in situa-models and expectations. But more likely our surprise
tions where the signaling is associated with cellularmay reflect at least three general shortcomings in our
growth, such as in regenerating tissues, hemopoeticcurrent knowledge. First, because many more studies
tissues, or sugar-fed moss cells. In the mouse, wherehave been performed examining the cell cycle charac-
the embryo is fed by placental sources, many of theteristics of hematopoetic cells and fibroblasts than, for
growth signals may be constitutive and cyclin D wouldexample, neural cells or lung cells, we likely do not
become less important. In regenerating tissues, the abil-understand the considerable differences in the cell cycle
ity of cyclin D to respond to signals and trigger newrequirements for specific cell types. Indeed, our knowl-
tissue growth would presumably be tightly linked to theedge of the expression of many G1 regulators during
growth and signaling state of the cells. A number ofdevelopment and in different tissues is somewhat frag-
critical pathways appear to regulate cell division in re-mentary. This differential expression may reflect varying
generating tissues, including the Wnt, Hedgehog (Hh),requirements for these regulators. For example, hema-
Notch, and Hox pathways. Both the Wnt and Hh path-topoetic cells require a high proliferative turnover, so
ways have been suggested to signal in part throughtheir dependency on cyclin D may reflect a requirement
cyclin D- and cyclin E-dependent pathways, although itfor “turbo-charged” proliferation. Second, different tis-
is not clear how much these pathways depend on Cdksues may exhibit varying degrees of embryonic plastic-
activation. It is notable that deficiencies in Wnt and Hhity, such that D-type cyclins are only required in tissues
genes do show defects in organogenesis in the mousewhere other redundant programs cannot be rewired to
embryo. So, as we begin to search for “cyclin D-indepen-compensate. These tissue-specific differences may un-
dent” pathways controlling proliferation during organo-derlie one of the most critical unsolved problems in
genesis, targets of Wnt, Hh, Notch, and Hox regulatorscancer biology, i.e., what determines the tissue selectiv-
would be particularly good candidates.ity of certain cancer genes (as an example, LOH for the
Models and Reductionism
RB and INK4 genes are selected for only in a few tissues).
If G1 cell cycle complexes are not absolutely required,
Finally, there may be varying levels of regulatory re- how did we develop that idea to begin with? In many
dundancy in different tissues. Inhibition of Cdk2 by cases, the genes encoding Cdks, cyclins, and many of
siRNA induced a stronger proliferation defect in their regulators were originally characterized in budding
Cdk4/Cdk6/ and cyclin D1/D2/D3/ MEFs or fission yeast. When Cdks were identified in mammals,
than in wild-type MEFs, suggesting that even if cyclin somatic cell genetic experiments perturbed Cdk activity
D-Cdk4/6 or cyclin E-Cdk2 complexes are dispensable, by expressing Cdk dominant-negative mutants and Cdk
inactivation of both would at least not sustain cell divi- inhibitors, or using antisense oligos, microinjection of
sion in embryonic fibroblasts and perhaps in other cell neutralizing antibodies into living cells and, more re-
types. In addition, these in vitro results suggest that if cently, by RNA interference. Based on numerous pub-
mice missing cyclin E-Cdk2 or cyclin D-Cdk4 complexes lished studies, we learned that Cdk inhibition certainly
are viable, perhaps both sets of regulators cannot be slows down the cell cycle of cultured mammalian cells.
removed. This hypothesis might be confirmed or dis- However, these experiments didn’t prove that Cdks are
proved by specific crosses, but the pentuple cyclin “essential” genes and certainly did not show that they
knockout will require multiple crosses, and linkage be- are necessary in all cell types and at all times in vivo.
tween Cdk2 and Cdk4 makes the probability of a recom- Cdk inhibition in asynchronous mammalian cells in-
binant too low, so a targeted knockout of Cdk4 in a duces accumulation of cells in G1, but never in 100%
Cdk2/Cdk6/ background is in progress (Malumbres of the cells. If Cdk inhibition is induced in synchronized
et al., 2004). Lastly, in addition to Cdk2, Cdk4, and Cdk6, cells, we see a delay in S phase entry (not an arrest!),
mammalian cells have many additional cyclins, Cdks, similar to that observed in D1/D2/D3/ MEFs (Fig-
and Cdk-like proteins that have been only thinly exam- ures 5 and 6 in Kozar et al. [2004]) and Cdk4/Cdk6/
ined, and these may provide compensating mechanisms MEFs (Figure 5 and 7 in Malumbres et al. [2004]). Histori-
in G1. cally, it was hard to discriminate whether a partial block
So, if cyclin D-Cdk complexes are not required for reflected an inefficient inactivation technique or that the
embryonic proliferation generally, what do they do? Ge- inhibited regulator was not the only important factor.
netic studies in Drosophila and nematodes are revealing. Although many studies have been done in MEFs and in
In Drosophila, recent studies suggest the idea that cyclin T cells, the majority of experiments in mammalian cell
D controls both mass accumulation and cell proliferation culture were performed using a limited number of highly
(Frei and Edgar, 2004; Meyer et al., 2000). Indeed, a transformed cell lines (mostly HeLa cells). In addition,
recent analysis suggests that cyclin D participates in the importance of cyclin-Cdk complexes in experimental
a pathway regulating oxygen sensing, possibly linking systems examining intact organs or tissues has been
cyclin D to respiratory homeostasis (Frei and Edgar, examined in very few cases.
2004). In nematodes, cyclin D does appear to control Experiments in cultured cells may have been overly
proliferation, but possibly only in those tissues where generalized in some cases. Statements such as “this
cell proliferation is linked to cell growth, such as postem- cyclin is required for G1 progression,” implying all G1
bryonic divisions (Park and Krause, 1999). Amazingly, progressions in all cell types, are common. The tendency
to generalize has many roots, but it may derive in partin cells of the moss Physcomitrella, cyclin D appears to
Cell
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from the yeast literature. Here, the simple and sharply more complex than the already intricate mitotic appa-
ratus.controlled growth responses in yeast (no sugar–no
growth) and the lesser degree of redundancy cause In conclusion, recent work in the field supports the
notion that a deeper understanding of the cell cycleyeast phenotypes to be stronger and more amenable
requires multiple model organisms. The mouse, in par-to a black-and-white description. Subsequent studies
ticular, provides avenues for both genetics and bio-in mammals adopted the same language.
chemistry. In addition, genetics in this organism pro-There are also limitations of the treatments used to
vides information about the cell cycle in embryos, adultinactivate cyclin D-Cdk or cyclin E-Cdk2 complexes
organisms, and, most importantly, the cell cycle’s variedthemselves. By employing Cdk inhibitors, antibody neu-
behavior in different tissues. Yet, despite the power oftralization, or dominant-negative variants of various Cdk
genetics and the common message provided so far bycomponents, there is a strong possibility that the inhib-
studies in the mouse, fly, worm, and yeast, all confirmingited complexes may disrupt the cellular machinery, for
that cyclins and Cdks promote cell proliferation, theexample by sequestering substrates. In contrast, the
details among various systems and models are oftencomplete absence of a complex may allow better com-
different. Even within a single organism, there can bepensation, thereby allowing a closely related cyclin-Cdk
considerable physiological differences in various ge-complex access to substrates. RNA interference should
netic backgrounds. In the mouse, the use of differentbehave more like a genetic null, and many investigators
strains can change—sometimes dramatically—the phe-feel that RNA interference is a preferred method to mimic
notype derived by the loss of a particular gene. Thethe loss-of-function phenotype. Another issue may be
amazement expressed by some editorials for the resultsthat genetic inactivation in the mouse embryo allows
that not all cyclins and Cdks are essential in vivo seemssufficient time for developmental compensation,
a bit out of proportion, given that the models were mostlywhereas acute inactivation of gene products (for exam-
derived from cultured cells. While simplifying facts, andple by a siRNA oligo or a drug) does not. In this regard,
delineating apparently “linear” pathways, help to explainan enlightening study (Sage et al., 2003) clearly illus-
our findings, ultimately, we need to avoid turning thetrates the important point that acute elimination of Rb’s
models into reductionist dogma.function in somatic cultured cells may have conse-
quences different than in the mouse knockout setting
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